[FG] Kyburz Diego

Steimer, A. et al. (2025) ‘Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort’, Clinical Rheumatology, 44(4), pp. 1589–1596. Available at: https://doi.org/10.1007/s10067-025-07393-0.

Kurth, S. et al. (2025) ‘Identification and proteomic profiling of CD90+ small EVs using a refined immunocapture separation approach targeting stromal-derived EV subpopulations in synovial fluid of arthritis patients’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2025.03.12.640750.

Kurth,Stefanie (2025) Immunocapture and proteomic profiling of synovial fluid-derived EV subpopulations in arthritis and functional characterization of EVs on macrophage polarization. Doctoral Thesis. University of Basel.

Lehmann, Anouk et al. (2024) ‘Risankizumab and Certolizumab Pegol Dual-Targeted Therapy for Crohn’s Disease and Axial Spondyloarthritis: A Case Report’, Case Reports in Gastroenterology, 19(1), pp. 22–30. Available at: https://doi.org/10.1159/000542759.

Lehmann, Julia et al. (2024) ‘Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis’, Arthritis Research and Therapy, 26(1). Available at: https://doi.org/10.1186/s13075-024-03329-2.

Poller, M. et al. (2024) ‘Does the Change of Weather Influence Disease Activity in Rheumatoid Arthritis Patients: Patients’ Self-Assessment via WebApp’, Journal of Clinical Medicine, 13(17). Available at: https://doi.org/10.3390/jcm13175336.

Hemmig AK et al. (2024) ‘Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis’, Rheumatology (United Kingdom), 63(6), pp. 1523–1527. Available at: https://doi.org/10.1093/rheumatology/kead450.

Trottet, C. et al. (2024) ‘Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases’, PLOS Digital Health, 3(6). Available at: https://doi.org/10.1371/journal.pdig.0000422.

Welsh, Joshua A. et al. (2024) ‘Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches’, Journal of Extracellular Vesicles, 13(2). Available at: https://doi.org/10.1002/jev2.12404.

Ciurea, Adrian et al. (2023) ‘Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry’, RMD Open, 9(4). Available at: https://doi.org/10.1136/rmdopen-2023-003455.

Riek, Myriam et al. (2023) ‘Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care’, Scientific Reports, 13(1). Available at: https://doi.org/10.1038/s41598-023-44841-w.

Alten R et al. (2023) ‘Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus’, Clinical Rheumatology, 42(9), pp. 2321–2334. Available at: https://doi.org/10.1007/s10067-023-06649-x.

Micheroli, Raphael et al. (2023) ‘Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry’, Clinical Rheumatology, 42(9), pp. 2377–2385. Available at: https://doi.org/10.1007/s10067-023-06662-0.

Giaglis, Stavros et al. (2023) ‘Mitochondrial DNA: A novel indicator of active inflammation in ANCA-Associated vasculitides’, Rheumatology (United Kingdom), 62(8), pp. 2930–2937. Available at: https://doi.org/10.1093/rheumatology/kead015.

Mensch, Noemi et al. (2023) ‘Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study’, RMD Open, 9(3). Available at: https://doi.org/10.1136/rmdopen-2023-003301.

Hawtin, Stuart et al. (2023) ‘Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy’, Cell Reports Medicine, 4(5). Available at: https://doi.org/10.1016/j.xcrm.2023.101036.

Fröhlich, Fabienne et al. (2023) ‘HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry’, Clinical Rheumatology, 42(5), pp. 1267–1274. Available at: https://doi.org/10.1007/s10067-022-06490-8.

Amstad A et al. (2023) ‘Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy’, Rheumatology (United Kingdom), 62(1), pp. 89–97. Available at: https://doi.org/10.1093/rheumatology/keac285.

Hemmig, Andrea Katharina et al. (2023) ‘Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study’, RMD open, 9(1). Available at: https://doi.org/10.1136/rmdopen-2022-002866.

Micheroli, Raphael et al. (2023) ‘Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients’, Journal of Rheumatology, 50(12), pp. 1587–1593. Available at: https://doi.org/10.3899/jrheum.2023-0137.

Schmitt C et al. (2022) ‘Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study’, Arthritis Research and Therapy, 24(1), p. 133. Available at: https://doi.org/10.1186/s13075-022-02815-9.

Dräger, Sarah et al. (2022) ‘Reversed Halo Sign on Chest Computed Tomography in a 33-Year-Old Man Without Immunosuppression’, American Journal of Medicine. 23.04.2023, 135(9), pp. e318–e320. Available at: https://doi.org/10.1016/j.amjmed.2022.04.009.

Van Hoovels L et al. (2022) ‘IgA rheumatoid factor in rheumatoid arthritis’, Clinical Chemistry and Laboratory Medicine, 60(10), pp. 1617–1626. Available at: https://doi.org/10.1515/cclm-2022-0244.

Ruocco A et al. (2022) ‘The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review’, Frontiers in Cell and Developmental Biology, 10, p. 957800. Available at: https://doi.org/10.3389/fcell.2022.957800.

Alten R et al. (2022) ‘Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study’, Clinical Rheumatology, 41(8), pp. 2361–2373. Available at: https://doi.org/10.1007/s10067-022-06176-1.

Hemmig AK et al. (2022) ‘Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data’, Seminars in Arthritis and Rheumatism, 55, p. 152017. Available at: https://doi.org/10.1016/j.semarthrit.2022.152017.

Hoyler, Thomas et al. (2022) ‘Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractants’, JCI Insight, 7(13). Available at: https://doi.org/10.1172/jci.insight.149825.

Du Fay De Lavallaz, Jeanne et al. (2022) ‘Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T’, Circulation, 145(24), pp. 1764–1779. Available at: https://doi.org/10.1161/CIRCULATIONAHA.121.058489.

Van Hoovels L et al. (2022) ‘Standardisation of ACPA tests: evaluation of a new candidate reference preparation’, Annals of the Rheumatic Diseases, 81(10), pp. 1379–1384. Available at: https://doi.org/10.1136/annrheumdis-2021-221849.

Van Hoovels L et al. (2022) ‘Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results’, RMD Open, 8(1). Available at: https://doi.org/10.1136/rmdopen-2021-002099.

Ciurea A et al. (2022) ‘Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: Data from a large, prospective, observational cohort’, RMD Open, 8(1). Available at: https://doi.org/10.1136/rmdopen-2021-002067.

Kyburz, D. (2022) ‘The painful joint Das schmerzhafte Gelenk’, Therapeutische Umschau, 80(1). Available at: https://doi.org/10.1024/0040-5930/a001399.

Arnold S. et al. (2022) ‘Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors’, Rheumatology (United Kingdom), 61(1), pp. 131–138. Available at: https://doi.org/10.1093/rheumatology/keab343.

Lehmann, Julia and Kyburz, Diego (2022) ‘Rheumatoid Arthritis’, Therapeutische Umschau, 80, pp. 27–33. Available at: https://doi.org/10.1024/0040-5930/a001403.

Giaglis S et al. (2021) ‘Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus’, RMD Open, 7(3). Available at: https://doi.org/10.1136/rmdopen-2021-002010.

Frei N, Caobelli F and Kyburz D. (2021) ‘Bilateral proximal hamstring muscle avulsion after treatment with immune checkpoint inhibitors and corticosteroids’, Swiss Medical Weekly, 151(35). Available at: https://doi.org/10.4414/SMW.2021.w30011.

Gilbert BTP et al. (2021) ‘Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis’, BMJ Open, 11(7), p. e048409. Available at: https://doi.org/10.1136/bmjopen-2020-048409.

Ciurea A et al. (2021) ‘Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort’, Annals of the Rheumatic Diseases, 80(2), pp. 238–241. Available at: https://doi.org/10.1136/annrheumdis-2020-218705.

Burkard T et al. (2021) ‘Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients’, Rheumatology Advances in Practice, 5(3), p. rkab087. Available at: https://doi.org/10.1093/rap/rkab087.

Tamborrini G, Kyburz D and Studler U (2021) ‘[CME Rheumatology 24: DISH of the Hand and Undifferentiated Polyarthritis].’, Praxis, 110(14), pp. 778–784. Available at: https://doi.org/10.1024/1661-8157/a003767.

Tamborrini G, Kyburz D and Studler U (2021) ‘[CME Rheumatology 24/Answers: DISH of the Hand and Undifferentiated Polyarthritis].’, Praxis, 110(16), pp. 958–960. Available at: https://doi.org/10.1024/1661-8157/a003768.

Khan, A.W. et al. (2020) ‘Erratum: Exercise-induced improvement of microvascular phenotype and reprogramming of p66ShcDNA methylation (European Heart Journal (2019) 40 (3948-3949) DOI: 10.1093/eurheartj/ehz830)’, European Heart Journal, 41(46). Available at: https://doi.org/10.1093/eurheartj/ehaa009.

Fallet B, Kyburz D and Walker U.A. (2020) ‘Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment’, Arthritis and Rheumatology, 72(9), pp. 1581–1582. Available at: https://doi.org/10.1002/art.41380.

Micheroli R et al. (2020) ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’, Annals of the Rheumatic Diseases, 79(9), pp. 1203–1209. Available at: https://doi.org/10.1136/annrheumdis-2019-215934.

Finckh A et al. (2020) ‘Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland’, RMD Open, 6(1). Available at: https://doi.org/10.1136/rmdopen-2020-001174.

Fisher B.A. et al. (2020) ‘Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren’s syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study’, The Lancet Rheumatology, 2(3), pp. e142–e152. Available at: https://doi.org/10.1016/s2665-9913(19)30135-3.

Fasler DA et al. (2020) ‘Rheumatoid cervical pannus: feasibility of volume and perfusion quantification using dynamic contrast enhanced time resolved MRI’, Acta Radiologica, 61(2), pp. 227–235. Available at: https://doi.org/10.1177/0284185119854200.

Quero, Lilian et al. (2020) ‘miR-221-3p Drives the Shift of M2-Macrophages to a Pro-Inflammatory Function by Suppressing JAK3/STAT3 Activation’, Frontiers in Immunology, 10. Available at: https://doi.org/10.3389/fimmu.2019.03087.

Streese, Lukas et al. (2020) ‘High-intensity interval training modulates retinal microvascular phenotype and DNA methylation of p66Shc gene: a randomized controlled trial (EXAMIN AGE)’, European Heart Journal, 41(15), pp. 1514–1519. Available at: https://doi.org/10.1093/eurheartj/ehz196.

Streese, Lukas et al. (2020) ‘Physical activity may drive healthy microvascular ageing via downregulation of p66 Shc’, European Journal of Preventive Cardiology, 27(2), pp. 168–176. Available at: https://doi.org/10.1177/2047487319880367.

Ankli B et al. (2019) ‘The target uric acid level in multimorbid patients with gout is difficult to achieve: Data from a longitudinal Swiss single-centre cohort’, Swiss Medical Weekly, 149(35-36), p. w20121. Available at: https://doi.org/10.4414/smw.2019.20121.

Hargreaves P et al. (2019) ‘Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome’, Arthritis research & therapy, 21(1), p. 175. Available at: https://doi.org/10.1186/s13075-019-1955-2.

Scholz GA et al. (2019) ‘The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis’, British Journal of Haematology, 186(1), pp. 101–112. Available at: https://doi.org/10.1111/bjh.15895.

Bühler, Silja et al. (2019) ‘Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study’, Rheumatology, 58(9), pp. 1585–1596. Available at: https://doi.org/10.1093/rheumatology/kez045.

Lechtenboehmer CA et al. (2019) ‘Brief Report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis’, Arthritis and Rheumatology, 71(1), pp. 43–49. Available at: https://doi.org/10.1002/art.40684.

Buttgereit F et al. (2018) ‘[S3 guidelines on treatment of polymyalgia rheumatica : Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (ÖGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations].’, Zeitschrift fur Rheumatologie, 77(5), pp. 429–441. Available at: https://doi.org/10.1007/s00393-018-0476-8.

Deiseroth A et al. (2018) ‘Retinal vessel diameters and physical activity in patients with mild to moderate rheumatic disease without cardiovascular comorbidities’, Frontiers in Psychiatry, 9(MAR), p. 176. Available at: https://doi.org/10.3389/fphys.2018.00176.

Ankli B et al. (2018) ‘Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout’, Scandinavian Journal of Rheumatology. 16.08.2017, 47(2), pp. 127–130. Available at: https://doi.org/10.1080/03009742.2017.1332239.

Quero L et al. (2017) ‘TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype’, Arthritis Research and Therapy. 02.11.2017, 19(1), p. 245. Available at: https://doi.org/10.1186/s13075-017-1447-1.

Tamborrini G and Kyburz D (2017) ‘[CME Rheumatology 13/Solution: Shoulder Pain, Muscle Weakness and Skin Rash].’, Praxis, 106(24), p. 1360. Available at: https://doi.org/10.1024/1661-8157/a002858.

Tamborrini G and Kyburz D (2017) ‘[CME Rheumatology 13: Shoulder Pain, Muscle Weakness and Skin Rash].’, Praxis, 106(23), pp. 1271–1272. Available at: https://doi.org/10.1024/1661-8157/a002857.

Walker UA et al. (2017) ‘Disease activity dynamics in rheumatoid arthritis: Patients” self-assessment of disease activity via WebApp’, Rheumatology (United Kingdom), 56(10), pp. 1707–1712. Available at: https://doi.org/10.1093/rheumatology/kex229.

Alpizar-Rodriguez D et al. (2017) ‘Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis’, Rheumatology (United Kingdom), 56(9), pp. 1579–1585. Available at: https://doi.org/10.1093/rheumatology/kex239.

Alpizar-Rodriguez D et al. (2017) ‘The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis’, Clinical Rheumatology. 21.01.2017, 36(3), pp. 677–682. Available at: https://doi.org/10.1007/s10067-017-3547-3.

Rizzi M et al. (2017) ‘Impact of tofacitinib treatment on human B-cells in vitro and in vivo’, Journal of Autoimmunity, 77, pp. 55–66. Available at: https://doi.org/10.1016/j.jaut.2016.10.005.

Imfeld, Stefan et al. (2017) ‘[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic’, Eur Heart J Cardiovasc Imaging, 19(8), pp. 933–940. Available at: https://doi.org/10.1093/ehjci/jex259.

Manigold,Tobias et al. (2016) ‘Gouty Arthritis of the Atlantodental Joint’, Arthritis and Rheumatology, 68(6), p. 1539. Available at: https://doi.org/10.1002/art.39645.

Franzen, Daniel et al. (2016) ‘Effect of rituximab on pulmonary function in patients with rheumatoid arthritis’, Pulmonary Pharmacology & Therapeutics, 37, pp. 9–24. Available at: https://doi.org/10.1016/j.pupt.2016.02.002.

Boehncke, Wolf-Henning et al. (2015) ‘The dermatologists” role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists’, Dermatology, 230(1), pp. 75–81. Available at: https://doi.org/10.1159/000367688.

Bühler, Silja et al. (2015) ‘Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases’, Swiss Medical Weekly, 145, p. w14159. Available at: https://doi.org/10.4414/smw.2015.14159.

Hruska-Plochan, Marian et al. (2015) ‘New and emerging roles of small RNAs in neurodegeneration, muscle, cardiovascular and inflammatory diseases’, Swiss Medical Weekly, 145, p. w14192. Available at: https://doi.org/10.4414/smw.2015.14192.

Micheroli, Raphael et al. (2015) ‘Correlation of findings in clinical and high resolution ultrasonography examinations of the painful shoulder’, Journal of Ultrasonography, 15(60), pp. 29–44. Available at: https://doi.org/10.15557/jou.2015.0003.

Engler A et al. (2014) ‘SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts’, Journal of Molecular Medicine. 19.03.2014, 92(7), pp. 757–767. Available at: https://doi.org/10.1007/s00109-014-1139-0.

Finckh, Axel et al. (2014) ‘Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: No significant effect in a randomized crossover trial’, Arthritis Research and Therapy, 16(1). Available at: https://doi.org/10.1186/s13075-014-0458-4.

Gabay, Cem et al. (2014) ‘Biological agents in monotherapy for the treatment of rheumatoid arthritis’, Swiss Medical Weekly, 144, p. w13950. Available at: https://doi.org/10.4414/smw.2014.13950.

Kyburz, Diego, Karouzakis, Emmanuel and Ospelt, Caroline (2014) ‘Epigenetic changes: the missing link’, Best Pract Res Clin Rheumatol, 28(4), pp. 87–577. Available at: https://doi.org/10.1016/j.berh.2014.10.014.

Zufferey P et al. (2013) ‘Recommendations for the use of ultrasound in rheumatoid arthritis: Literature review and SONAR score experience’, Swiss Medical Weekly, 143, p. w13861. Available at: https://doi.org/10.4414/smw.2013.13861.

Scherrer CB et al. (2013) ‘Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs’, Arthritis Care and Research, 65(12), pp. 2032–2040. Available at: https://doi.org/10.1002/acr.22077.

Heijnen IA et al. (2013) ‘Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: A EUSTAR group-based study’, Clinical and Experimental Rheumatology, 31(SUPPL.76), pp. 96–102.

Présumey J et al. (2013) ‘Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis’, Annals of the Rheumatic Diseases. 12.01.2013, 72(10), pp. 1717–1724. Available at: https://doi.org/10.1136/annrheumdis-2012-202403.

Schöni M et al. (2013) ‘Long-term survival of GSB III elbow prostheses and risk factors for revisions’, Archives of Orthopaedic and Trauma Surgery. 18.07.2013, 133(10), pp. 1415–1424. Available at: https://doi.org/10.1007/s00402-013-1815-5.

Kyburz, Diego and Finckh, Axel (2013) ‘The importance of early treatment for the prognosis of rheumatoid arthritis’, Swiss Medical Weekly, 143. Available at: https://doi.org/10.4414/smw.2013.13865.

Niederer, F. et al. (2013) ‘Serum levels of BAFF in patients with ankylosing spondylitis and treated with anti-TNF Taux sériques de BAFF chez les patients atteints de spondylarthrite ankylosante et traités par anti-TNF’, Revue du Rhumatisme (Edition Francaise), 80(4), pp. 417–419. Available at: https://doi.org/10.1016/j.rhum.2013.01.009.

Niederer F et al. (2013) ‘BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment’, Joint Bone Spine. 16.11.2012, 80(4), pp. 433–434. Available at: https://doi.org/10.1016/j.jbspin.2012.10.004.

Kyburz, D. and Niederer, F. (2013) ‘The role of sirtuins in arthritis’, in Studies on Arthritis and Joint Disorders. Springer New York (Studies on Arthritis and Joint Disorders), pp. 333–348. Available at: https://doi.org/10.1007/978-1-4614-6166-1_18.

Finckh,Axel et al. (2012) ‘Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists’, Annals of the Rheumatic Diseases. 14.03.2012, 71(10), pp. 1680–1685. Available at: https://doi.org/10.1136/annrheumdis-2011-201016.

Meier FM et al. (2012) ‘Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis’, Journal of Biological Chemistry. 05.07.2012, 287(34), pp. 28378–28385. Available at: https://doi.org/10.1074/jbc.M111.312884.

Niederer F et al. (2012) ‘Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance’, Arthritis and Rheumatism. 12.12.2011, 64(6), pp. 1771–1779. Available at: https://doi.org/10.1002/art.34334.

von Kempis J et al. (2012) ‘Use of abatacept in rheumatoid arthritis: Recommendations based on current evidence’, Swiss Medical Weekly, 142(MAY). Available at: https://doi.org/10.4414/smw.2012.13581.

Bombardieri M et al. (2011) ‘A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells’, Annals of the Rheumatic Diseases. 27.07.2011, 70(10), pp. 1857–1865. Available at: https://doi.org/10.1136/ard.2011.150219.

Niederer F et al. (2011) ‘SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance’, Annals of the Rheumatic Diseases. 08.07.2011, 70(10), pp. 1866–1873. Available at: https://doi.org/10.1136/ard.2010.148957.

Raza,Karim et al. (2011) ‘Delays in assessment of patients with rheumatoid arthritis: Variations across Europe’, Annals of the Rheumatic Diseases, 70(10), pp. 1822–1825. Available at: https://doi.org/10.1136/ard.2011.151902.

Micheroli R et al. (2011) ‘[The rheumatic hand - diagnostics in practice].’, Praxis, 100(18), pp. 106–1097. Available at: https://doi.org/10.1024/1661-8157/a000655.

Kyburz D and Corr M (2011) ‘Th17 cells generated in the absence of TGF-β induce experimental allergic encephalitis upon adoptive transfer’, Expert Review of Clinical Immunology, 7(3), pp. 283–285. Available at: https://doi.org/10.1586/eci.11.7.

Stanczyk J et al. (2011) ‘Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation’, Arthritis and Rheumatism, 63(2), pp. 373–381. Available at: https://doi.org/10.1002/art.30115.

Duroux-Richard I et al. (2011) ‘MicroRNAs as new player in rheumatoid arthritis’, Joint Bone Spine, 78(1), pp. 17–22. Available at: https://doi.org/10.1016/j.jbspin.2010.06.003.

Kyburz D et al. (2011) ‘The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.’, Rheumatology (Oxford, England). 21.01.2011, 50(6), pp. 1106–1110. Available at: https://doi.org/10.1093/rheumatology/keq424.

Strobel,Klaus et al. (2010) ‘18F-Fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis’, European Journal of Nuclear Medicine and Molecular Imaging. 27.05.2010, 37(9), pp. 1760–1765. Available at: https://doi.org/10.1007/s00259-010-1464-7.

Finckh A et al. (2010) ‘Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients’, Joint Bone Spine. 14.05.2010, 77(4), pp. 313–318. Available at: https://doi.org/10.1016/j.jbspin.2010.02.021.

Dudler, Jean et al. (2010) ‘Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.’, Swiss medical weekly, 140, p. w13073. Available at: https://doi.org/10.4414/smw.2010.13073.